Roche and Pfizer top the list, with Pfizer showing a 23% increase over 2009.
According to research firm Kalorama Information, global R&D spending in the pharmaceutical sector increased from just $35.3 billion in 1996 to more than $95 billion in 2009, so we know the investable money is there. Let's have a look at the 10 biggest pharmaceuticals R&D budgets in fiscal 2012 and see how they compare to corporate R&D spending in 2009.
Kalorama's Research on Pharmaceutical R&D can be found here
| http://www.kaloramainformation.com/Outsourcing-Drug-Discovery-6948227/ |
